Healthcare Sales & Marketing Network News: TAVI

Searching News Database: TAVI

HSMN NewsFeed - 23 Nov 2022
BioMarin Announces Advancements in FDA Review of ROCTAVIAN(TM) (Valoctocogene Roxaparvovec) for Adults with Severe Hemophilia A
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 30 Sep 2022
Accuray Announces First CyberKnife(R) Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients
Devices Oncology

HSMN NewsFeed - 24 Jun 2022
BioMarin Receives Positive CHMP Opinion in Europe for Valoctocogene Roxaparvovec Gene Therapy to Treat Adults with Severe Hemophilia A
Biopharmaceuticals Regulatory

HSMN NewsFeed - 28 Jan 2022
FDA Accepts Label Update for Plasma IQ(TM), the First FDA-Cleared Handheld Plasma Energy Device
Devices Dermatology FDA

HSMN NewsFeed - 4 Oct 2021
Novavax Announces Leadership Appointment and Updates
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Sep 2021
Open Stent Solution closes �2.5M Seed financing round for its breakthrough open-stent TMVR device
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 20 May 2021
TricValve(R) Transcatheter Bicaval Valves System Receives CE Mark
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 18 May 2021
Late-Breaking Registry Data at EuroPCR Congress Demonstrate Reduced Paravalvular Leak and Low Permanent Pacemaker Rates for the ACURATE neo2(TM) Aortic Valve System
Devices Interventional Cardiology

HSMN NewsFeed - 17 May 2021
Abbott Receives CE Mark for Navitor(TM), the Latest-Generation Transcatheter Aortic Valve Implantation (TAVI) System to Treat Aortic Stenosis
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 11 May 2021
Nuvalent Completes $135 Million Series B Financing to Advance Portfolio of Novel Precisely Targeted Kinase Inhibitors for Treatment-Resistant Cancers
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 10 May 2021
Medtronic Launches New Pediatric Monitor That Alerts Clinicians to Potential Airway Obstructions During Ventilation
Devices Monitoring Product Launch

HSMN NewsFeed - 3 May 2021
Medtronic Announces CE Mark of Evolut(TM) PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 16 Dec 2020
Vivace Therapeutics Announces $30 Million Series C Financing to Fund Clinical Programs Targeting the Hippo Pathway
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 18 Nov 2020
Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 9 Nov 2020
OrbusNeich(R) Medical and P+F Products & Features(R) announce new partnership
Devices Interventional Cardiology Distribution

HSMN NewsFeed - 28 Sep 2020
Boston Scientific Launches ACURATE neo2(TM) Aortic Valve System in Europe
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 27 Aug 2020
Healeon Announces FDA 510(k) Clearance for Duet Office-Based Blood Separation and Concentration System
Devices FDA

HSMN NewsFeed - 24 Aug 2020
Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 10 Aug 2020
Werewolf Therapeutics Appoints Business Leader, Ellen Lubman, as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 May 2020
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN(R) Intellectual Property Litigation
Biopharmaceuticals Litigation Licensing

HSMN NewsFeed - 1 May 2020
Suneva Medical Increases Its Leadership in Regenerative Aesthetics with New Partnership
Devices Dermatology Distribution

HSMN NewsFeed - 10 Mar 2020
TriGUARD 3(TM) Cerebral Embolic Protection Device Receives CE Mark for Use in Transcatheter Heart Procedures
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 9 Mar 2020
Relmada Therapeutics Appoints CNS Specialist Thomas C. Wessel, M.D., Ph.D., as Executive Vice President, Head of Research and Development
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 5 Mar 2020
Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav(TM) Delivery System for the Company's Portico(TM) Valve
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 30 Jan 2020
SutroVax Announces Executive Appointment
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2019
Black Diamond Therapeutics Closes $85 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 6 Nov 2019
Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 1 Oct 2019
Nektar Announces Key Executive Promotions
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Oct 2019
Avidity Biosciences Appoints Sarah Boyce as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jul 2019
Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jun 2019
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 16 Apr 2019
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 6 Mar 2019
Patricia Altavilla Appointed as Chief Executive Officer at Suneva Medical
Devices Dermatology Personnel

HSMN NewsFeed - 4 Jan 2019
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
Biopharmaceuticals Generics Personnel

HSMN NewsFeed - 26 Dec 2018
Venus Medtech Completes Merger with Keystone Heart, Ltd.
Devices Interventional Cardiology Mergers & Acquisitions

HSMN NewsFeed - 1 Oct 2018
Orexo Internalizes Contract Field Force in the US to Further Strengthen the Commercial Organization
Biopharmaceuticals Drug Delivery Distribution

HSMN NewsFeed - 25 Sep 2018
Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD
Devices Interventional Mergers & Acquisitions

HSMN NewsFeed - 28 Aug 2018
Daiichi Sankyo Presents First Snapshot Analyses from Global ETNA-AF Programme of Oral, Once-daily LIXIANA(R) (edoxaban) in Patients with Nonvalvular Atrial Fibrillation in Routine Clinical Practice
Biopharmaceuticals

HSMN NewsFeed - 27 Aug 2018
Tris Pharma Announces Hiring of New Vice President of Quality & Compliance
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 13 Aug 2018
New Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA(R) (edoxaban)
Biopharmaceuticals

HSMN NewsFeed - 16 Jul 2018
Aurobindo Signs a Definitive Agreement to Acquire Apotex' Businesses in Poland, Czech Republic, the Netherlands, Spain and Belgium
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 20 Jun 2018
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary(R)
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 19 Apr 2018
BD Unveils Suite of Diagnostic Informatics and Automation Innovations
Diagnostics Product Launch

HSMN NewsFeed - 3 Apr 2018
Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of R&D and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2018
Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 29 Nov 2017
Codiak BioSciences Closes $76.5 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Nov 2017
Allergan Receives FDA Approval For Use of VRAYLAR(TM) (cariprazine) in the Maintenance Treatment of Schizophrenia
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 9 Oct 2017
The MANTA Large Bore Vascular Closure Device to be Evaluated in a 500-patient European Post Market Clinical Registry
Devices Interventional Cardiology

HSMN NewsFeed - 17 Jul 2017
CHMP Issues a Positive Opinion for Daiichi Sankyo's Once-Daily LIXIANA(R) (edoxaban) in Patients with Atrial Fibrillation Undergoing Cardioversion
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 7 Jul 2017
UK Supreme Court Rules In Lilly's Favor On Alimta Vitamin Regimen Patents
Biopharmaceuticals Litigation

HSMN NewsFeed - 17 May 2017
Statement Regarding Xifaxan Intellectual Property Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 16 May 2017
The Boston Scientific LOTUS(TM) Valve System Demonstrated Superior Efficacy to CoreValve(R) in Global REPRISE III Trial at One Year
Devices Interventional Cardiology

HSMN NewsFeed - 16 May 2017
Boston Scientific Closes Symetis Acquisition
Devices Interventional Cardiology Mergers & Acquisitions

HSMN NewsFeed - 2 May 2017
Medeon Biodesign Announces Approval to Begin CE Clinical Study for the XPro(TM) Large Bore Vascular Closure System
Devices Interventional Regulatory

HSMN NewsFeed - 2 May 2017
Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Navamedic ASA for Mysimba(R) (naltrexone HCl / bupropion HCl prolonged release) in Five Nordic Countries
Biopharmaceuticals Distribution

HSMN NewsFeed - 28 Apr 2017
Venus Medtech's TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 12 Apr 2017
Cellectar Biosciences Strengthens Management Team with Appointment of John Friend, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 4 Apr 2017
Teva Announces FDA Approval of AUSTEDO(TM) (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington�s Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 30 Mar 2017
Symetis and Boston Scientific Reach USD 435 Million Purchase Agreement
Devices Interventional Cardiology Mergers & Acquisitions

HSMN NewsFeed - 30 Mar 2017
Boston Scientific Announces Agreement to Acquire Symetis
Devices Interventional Cardiology Mergers & Acquisitions

HSMN NewsFeed - 15 Mar 2017
Julie G. Anderson Joins BioVie as Independent Director and Investor
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Mar 2017
Keystone Heart and Venus Medtech Announce Partnership for Cerebral Embolic Protection with Transcatheter Heart Valve Systems (TAVR) in China and Key Asian Markets
Devices Interventional Cardiology

HSMN NewsFeed - 28 Feb 2017
RenalGuard(R) Shown to Significantly Protect High-Risk Patients Undergoing Coronary Interventional Procedures from Acute Kidney Injury
Devices Interventional

HSMN NewsFeed - 27 Feb 2017
BrainStorm Names Dr. June S. Almenoff and Arturo O. Araya to its Board of Directors as Company Prepares for Clinical and Commercial Success
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 23 Feb 2017
Pernix Therapeutics Prevails in Zohydro(R) ER ANDA Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 7 Feb 2017
Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman
Biopharmaceuticals Generics Personnel

HSMN NewsFeed - 17 Jan 2017
Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
Biopharmaceuticals

HSMN NewsFeed - 9 Jan 2017
Xeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jan 2017
Allergan Announces FDA Approval of NATRELLE INSPIRA(R) SoftTouch Breast Implants
Devices FDA

HSMN NewsFeed - 13 Dec 2016
Supernus Wins Appeal Case on Oxtellar XR(R)
Biopharmaceuticals Neurology Litigation

HSMN NewsFeed - 8 Dec 2016
Orexo Appeals Zubsolv(R) US District Court Decision
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 2 Dec 2016
Allergan Announces Settlement of a DELZICOL(R) (mesalamine) Patent Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 23 Nov 2016
Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 22 Nov 2016
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
Devices Ophthalmology FDA

HSMN NewsFeed - 10 Nov 2016
Allergan Announces Launch of TAYTULLA(TM) (Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules) 1 mg/20 mcg, the First and Only Oral Contraceptive Softgel Capsule
Biopharmaceuticals Product Launch

HSMN NewsFeed - 8 Nov 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave(R) (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand
Biopharmaceuticals Distribution

HSMN NewsFeed - 28 Oct 2016
Allergan Introduces RESTASIS MULTIDOSE(TM) (Cyclosporine Ophthalmic Emulsion) 0.05%, a New Delivery System for the One and Only FDA Approved Treatment to Help Patients Produce More of Their Own Tears
Biopharmaceuticals Ophthalmology FDA Product Launch

HSMN NewsFeed - 25 Oct 2016
Allergan Successfully Completes Vitae Tender Offer
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 17 Oct 2016
Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 17 Oct 2016
Teva Receives Positive Opinion from European Medicines Agency�s Committee for Medicinal Products for Human Use (CHMP) to Extend Indication of Trisenox(R) for First Line Treatment of Low- to Intermediate Risk Acute Promyelocytic Leukemia (APL)
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 6 Oct 2016
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Oct 2016
Allergan plc Enters Into Licensing Agreement with AstraZeneca to Obtain Worldwide Rights to MEDI2070 Inflammatory Disorder Development Program
Biopharmaceuticals Gastroenterology Licensing

HSMN NewsFeed - 29 Sep 2016
Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
Biopharmaceuticals Generics FDA Litigation

HSMN NewsFeed - 23 Sep 2016
Momenta Pharmaceuticals Appoints Corey N. Fishman to Board of Directors
Biopharmaceuticals Generics Personnel

HSMN NewsFeed - 20 Sep 2016
Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH
Biopharmaceuticals Gastroenterology Mergers & Acquisitions

HSMN NewsFeed - 19 Sep 2016
Boston Scientific Receives CE Mark For LOTUS Edge(TM) Valve System
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 15 Sep 2016
Teva Strengthens Injectables Portfolio with the Launch of an Authorized Generic of Cubicin(R) (Daptomycin for Injection) in the United States
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 3 Aug 2016
Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceutical
Biopharmaceuticals Distribution Acquisitions

HSMN NewsFeed - 22 Jul 2016
VIVUS Announces Favorable Markman Ruling in Qsymia(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 23 Jun 2016
Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ(R) (ceftazidime and avibactam)
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Jun 2016
German Supreme Court Grants Lilly Appeal in Alimta(R) Vitamin Regimen Patent Lawsuit
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 6 Jun 2016
Allergan Announces FDA Approval of BYVALSON(TM) (nebivolol and valsartan)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 31 May 2016
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 24 May 2016
Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 16 May 2016
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
Devices Ophthalmology

HSMN NewsFeed - 9 May 2016
Allergan and Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids
Biopharmaceuticals

HSMN NewsFeed - 2 May 2016
Endo Announces U.S. District Court Ruling Upholding OPANA(R) ER Intellectual Property
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 2 May 2016
Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR(R) (rosuvastatin)
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 29 Apr 2016
Allergan Receives CHMP Positive Opinion For ENZEPI(R) (Pancrelipase) For Patients With Exocrine Pancreatic Insufficiency (EPI)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 6 Apr 2016
Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer Transaction
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Mar 2016
Shire Wins Patent Trial Against Watson Concerning LIALDA(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 29 Mar 2016
Lannett Receives FDA Approvals For Two Products
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 23 Mar 2016
Perrigo And Allergan Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex(R) 1200mg ER Tablets
Biopharmaceuticals Product Launch

HSMN NewsFeed - 17 Mar 2016
Allergan Confirms Generic Abraxane(R) Patent Challenge
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 16 Mar 2016
Allergan Announces U.S. Availability of VRAYLAR(TM) (cariprazine) for Treatment of Bipolar Mania and Schizophrenia in Adults
Biopharmaceuticals Product Launch

HSMN NewsFeed - 10 Mar 2016
Allergan Receives Complete Response Letter from FDA for Prior Approval Supplement for RESTASIS(R) (Cyclosporine Ophthalmic Emulsion) 0.05% Multi-Dose Preservative-Free Bottle
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 7 Mar 2016
Anthera Pharmaceuticals Announces Appointment of Dr. James Pennington as Interim Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 29 Feb 2016
Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA
Biopharmaceuticals Generics Gastroenterology FDA

HSMN NewsFeed - 24 Feb 2016
FDA Accepts and Grants Priority Review for AVYCAZ(R) (ceftazidime and avibactam) Supplemental New Drug Application (sNDA)
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Feb 2016
Cipher Pharmaceuticals Inc. announces Canadian launch of Actikerall(TM)
Biopharmaceuticals Dermatology Product Launch

HSMN NewsFeed - 16 Feb 2016
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Feb 2016
Supernus Prevails in Oxtellar XR(R) ANDA Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 29 Jan 2016
Allergan's Rapastinel Receives FDA Breakthrough Therapy Designation for Adjunctive Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 26 Jan 2016
RenalGuard Solutions(TM), Inc., Announces New European Clinical Trial to Evaluate the Long-Term Impact of RenalGuard Therapy(R) in Patients at High Risk for CI-AKI
Devices Interventional Cardiology

HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Jan 2016
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Jan 2016
VIBERZI(TM) (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 14 Dec 2015
Allergan Announces U.S. Availability of VIBERZI(TM) (eluxadoline) for Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults
Biopharmaceuticals Gastroenterology Product Launch

HSMN NewsFeed - 23 Nov 2015
Pfizer and Allergan to Combine
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Nov 2015
Allergan Enters Into Licensing Agreement with Mimetogen Pharmaceuticals to Develop and Commercialize Tavilermide (MIM-D3) Topical Dry Eye Treatment
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 4 Nov 2015
Allergan to Acquire earFold(TM), an Innovative Medical Device for the Correction of Prominent Ears
Devices Acquisitions

HSMN NewsFeed - 3 Nov 2015
CureVac raises $110 Million in a private placement
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 29 Oct 2015
Allergan plc Confirms Discussions Regarding Potential Business Combination Transaction With Pfizer Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Biopharmaceuticals Gastroenterology Acquisitions

HSMN NewsFeed - 1 Oct 2015
U.S. FDA Approves JUVEDERM(R) ULTRA XC for Use in Lips
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 15 Sep 2015
Depomed Files New Patent Infringement Lawsuit Against NUCYNTA(R) ER ANDA Filer
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 17 Jun 2015
Allergan to Acquire KYTHERA Biopharmaceuticals
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 20 May 2015
Post-Market Study Evaluating The Boston Scientific Lotus(TM) Valve System Demonstrates Extremely Low PVL Rates
Devices Interventional Cardiology

HSMN NewsFeed - 18 May 2015
Actavis Launches NAMZARIC(TM) (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology Product Launch

HSMN NewsFeed - 28 Apr 2015
Endo Announces Appointment of Matthew J. Maletta as Chief Legal Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Apr 2015
Cipher Pharmaceuticals announces outcome of Markman hearing in patent infringement suit for Absorica(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 13 Apr 2015
Actavis and Medicines360 Announce U.S. Availability of LILETTA(TM) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years
Biopharmaceuticals Product Launch

HSMN NewsFeed - 13 Apr 2015
Depomed Announces Gralise(R) ANDA Litigation Settlement Confirming Exclusivity to 2024 and Dismissing Appeal
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 13 Mar 2015
Actavis Receives FDA Approval of SAPHRIS(R) for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Feb 2015
SCYNEXIS Names Marco Taglietti, M.D., Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Dec 2014
Actavis and Adamas Announce FDA Approval of Namzaric(TM), a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 18 Nov 2014
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Nov 2014
Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Nov 2014
Blueprint Medicines Secures $50 Million in Series C Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 10 Oct 2014
Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Oct 2014
Claret Medical Announces First Patient Treated in U.S. Pivotal Trial Evaluating Cerebral Protection During Transcatheter Aortic Valve Replacement (TAVR)
Devices Interventional Cardiology

HSMN NewsFeed - 15 Sep 2014
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Sep 2014
Symetis Receives CE Mark Approval for Transfemoral Transcatheter Aortic Heart Valve System ACURATE neo(TM), and Launches Product With First Commercial Implantations
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 21 Aug 2014
Direct Flow Medical(R), Inc. Receives CE Mark for 23mm Valve and for Implantation of All Sizes of Its Transcatheter Aortic Heart Valve Without Use of Contrast
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 31 Jul 2014
Intra-Cellular Therapies Announces the Appointment of Michael Halstead as Senior Vice President and General Counsel
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 7 Jul 2014
JenaValve Names David J. Drachman Chief Executive Officer
Devices Cardiology Personnel

HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 May 2014
Primary Endpoint Data Presented on Performance and Safety of the JenaValve TAVI System
Devices Interventional Cardiology

HSMN NewsFeed - 1 May 2014
Dr. Edward Rudnic Appointed CEO of QRxPharma
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Apr 2014
JenaValve Expands Series C Venture Financing Round
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 1 Apr 2014
Actavis Acquires Silom Medical Company
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 19 Mar 2014
BioAlliance Pharma: Sitavig(R) Licensing Strategy
Biopharmaceuticals Dermatology Licensing

HSMN NewsFeed - 11 Mar 2014
Sorrento Therapeutics Appoints Mark Durand to its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 18 Feb 2014
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Feb 2014
Pernix Attracts $65 Million Institutional Investment; Appoints Doug Drysdale as CEO; Settles Pending Legal Liabilities
Biopharmaceuticals Personnel Litigation

HSMN NewsFeed - 31 Jan 2014
Actavis Announces Refocused Global Business Structure to Maximize Evolution into Global Specialty Pharmaceuticals Leadership
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jan 2014
Antares Pharma Announces Availability of OTREXUP (Methotrexate) Injection for Subcutaneous Use to Treat Rheumatoid Arthritis (RA) and Psoriasis in Adults, and Polyarticular Idiopathic Arthritis (pJIA) in Children
Biopharmaceuticals Drug Delivery Product Launch

HSMN NewsFeed - 14 Jan 2014
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
Biopharmaceuticals Urology Gastroenterology Personnel

HSMN NewsFeed - 19 Dec 2013
Vensun Pharmaceuticals, Inc. Completes Series B Financing
Biopharmaceuticals Generics Venture Capital

HSMN NewsFeed - 13 Dec 2013
QRxPharma Completes A$11.6 Million Capital Raising
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Nov 2013
Antares Pharma Appoints David H. Bergstrom Ph.D. as Senior Vice President Pharmaceutical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Nov 2013
Boston Scientific Announces First Commercial Implants Of The Lotus(TM) Valve System in Europe
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 24 Oct 2013
Colibri Heart Valve Concludes Patient Enrollment in First-in-Human Study of Proprietary TAVI System in Dominican Republic
Devices Interventional Cardiology

HSMN NewsFeed - 30 Sep 2013
Amneal Pharmaceuticals to Acquire Four Generic Products
Biopharmaceuticals Generics Acquisitions

HSMN NewsFeed - 9 Sep 2013
Keystone Heart's TriGuard(TM) Cerebral Protection Device Receives CE Marking
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 3 Sep 2013
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 28 Aug 2013
Grifols and Aradigm Corporation Complete the Closing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin(R)
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 12 Aug 2013
Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Aug 2013
Symetis Announces Successful, First Time Implantation of Its ACURATE TA(TM) and ACURATE TF(TM) TAVI Systems in Japan
Devices Interventional Cardiology

HSMN NewsFeed - 7 Aug 2013
Supernus Sues Watson for Infringement of Oxtellar XR(TM) Patents
Biopharmaceuticals Generics Neurology Litigation

HSMN NewsFeed - 5 Aug 2013
Elite Pharmaceuticals, Inc. Appoints Nasrat Hakim asElite Pharmaceuticals, Inc. Appoints Nasrat Hakim as President and Chief Executive Officer President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jul 2013
JenaValve Raises $62.5 Million In Venture Funding
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 22 Jul 2013
Forest Laboratories, Inc. Announces Additional Settlement Agreement in BYSTOLIC(R) Patent Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 19 Jun 2013
Actavis And Kissei File Lawsuits Against Sandoz And Hetero For Infringement Of Rapaflo(R) Patent
Biopharmaceuticals Urology Generics Litigation

HSMN NewsFeed - 28 May 2013
RenalGuard Therapy(R) Shows Promise in TAVI Procedures
Devices Interventional Cardiology

HSMN NewsFeed - 21 May 2013
Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system
Devices Cardiology

HSMN NewsFeed - 20 May 2013
Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
Devices Interventional Cardiology

HSMN NewsFeed - 16 May 2013
Colibri Heart Valve to Present Six Month Follow-up Results from First Clinical Use at Upcoming EuroPCR Meeting
Devices Interventional Cardiology

HSMN NewsFeed - 1 May 2013
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 5 Apr 2013
Actavis and Valeant Announce Actavis as Exclusive Authorized Generic Marketer of Zovirax(R) Ointment; Co-Promotion Agreements on Zovirax(R) Cream and Cordran(R) Tape
Biopharmaceuticals Generics Distribution

HSMN NewsFeed - 7 Mar 2013
Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Feb 2013
Actavis' Generic Suboxone(R) Receives FDA Approval
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 13 Feb 2013
Loma Vista Medical Reports That It is Ramping up Sales in U.S. and Europe of its FDA-Cleared and CE-Marked TRUE Dilatation(TM) Balloon Valvuloplasty Catheter Specifically Designed to Reduce �Rapid Pacing� Time and Prevent Balloon Failure
Devices Interventional Cardiology Distribution

HSMN NewsFeed - 6 Feb 2013
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 5 Feb 2013
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 4 Feb 2013
JenaValve Appoints John F. Migliazza, Chief Operating Officer
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 31 Jan 2013
Pfizer Wins RAPAMUNE(R) Patent Case in Delaware District Court
Biopharmaceuticals Litigation

HSMN NewsFeed - 29 Jan 2013
Colibri Heart Valve Announces Issuance of a Patent for a Pre-mounted, Pre-packaged, Sterilized Dry Heart Valve on a Delivery System
Devices Interventional Cardiology

HSMN NewsFeed - 25 Jan 2013
FDA Approves OXYTROL(R) FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women
Biopharmaceuticals Drug Delivery Urology FDA

HSMN NewsFeed - 23 Jan 2013
Watson Acquires Uteron Pharma SA
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 19 Dec 2012
Regado Biosciences, Inc. Secures $51 Million Series E Financing
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 5 Dec 2012
Colibri Heart Valve, LLC Announces Successful Clinical Use of the First Ready-to-Use Transcatheter Aortic Heart Valve System
Devices Interventional Cardiology

HSMN NewsFeed - 4 Dec 2012
Vascular Closure Systems, Inc. Announces the Successful Completion of the First in Human (FIH) Clinical Trial of the 6 Fr. / 7 Fr. FastSeal(R) Bioabsorbable Vascular Access Closure System
Devices Interventional Cardiology

HSMN NewsFeed - 17 Oct 2012
Loma Vista Medical Receives FDA Clearance for its TRUE Dilatation(TM) Balloon Valvuloplasty Catheter
Devices Interventional Cardiology FDA

HSMN NewsFeed - 23 May 2012
APP Pharmaceuticals Acquires Three Products from Nexus
Biopharmaceuticals Generics Acquisitions

HSMN NewsFeed - 16 May 2012
Mitralign Raises $35 Million Series D Financing
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 10 May 2012
Cardionovum(R) Will Launch Two Drug-Eluting Balloon (DEB) Dilatation Catheter Product Families at EuroPCR 2012
Devices Interventional Cardiology

HSMN NewsFeed - 10 May 2012
Loma Vista Medical receives CE mark for its TRUE Dilatation(TM) Balloon Valvuloplasty Catheter
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 9 May 2012
Micro Interventional Devices, Inc. Secures Bridge Financing to Advance Clinical Development of Permaseal(TM)
Devices Surgery Cardiology Venture Capital

HSMN NewsFeed - 27 Apr 2012
Watson Announces Restructuring of Senior Leadership to Support Expanded Global Businesses
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Apr 2012
MEDA: Maria Carell Appointed Regional Director for the US
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jan 2012
VasoStitch Completes Successful In Vivo Study of Its Breakthrough Access-and-Closure System for Nonsurgical Deployment of Transcatheter Therapies
Devices Interventional

HSMN NewsFeed - 16 Jan 2012
Terumo Americas Holding Acquires Onset Medical Corporation, a Leader in Innovative Sheath Technology Designed for Multiple, Minimally Invasive Clinical Applications
Devices Mergers & Acquisitions

HSMN NewsFeed - 13 Dec 2011
St. Jude Medical Announces First Implant in European Clinical Trial Studying Portico Transcatheter Aortic Heart Valve
Devices Interventional Cardiology

HSMN NewsFeed - 4 Nov 2011
Medtronic�s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
Devices Interventional Cardiology

HSMN NewsFeed - 18 Oct 2011
Colibri Heart Valve, LLC Announces Appointment of Joseph B. Horn, President and CEO
Devices Cardiology Personnel

HSMN NewsFeed - 13 Oct 2011
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 30 Sep 2011
JenaValve Technology is First in Receiving CE Certification for a True Second-Generation Transapical TAVI System
Devices Cardiology Regulatory

HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Aug 2011
Study Shows Medtronic CoreValve(R) System Efficacy and Durability Through Four Years in Longest-Term Industry Data Available
Devices Interventional Cardiology

HSMN NewsFeed - 7 Jun 2011
St. Jude Medical Announces First Implant of Portico Transcatheter Heart Valve
Devices Interventional Cardiology

HSMN NewsFeed - 20 May 2011
Positive Clinical Outcomes Reported with Medtronic CoreValve(R) System
Devices Interventional Cardiology

HSMN NewsFeed - 19 May 2011
Study Provides Insight on Medtronic CoreValve(R) System Implants Through Subclavian Approach
Devices Interventional Cardiology

HSMN NewsFeed - 20 Apr 2011
AngioScore Announces Completion of $12 Million Financing
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 21 Mar 2011
Lithera Announces the Appointment of George W. Mahaffey as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Feb 2011
Largest Study of Medtronic CoreValve(R) System Confirms Positive Clinical Outcomes
Devices Interventional Cardiology

HSMN NewsFeed - 9 Feb 2011
CardiAQ Valve Technologies (CVT) appoints Dr. Kalathi Thyagarajan as Vice President of Regulatory Affairs & Quality Assurance
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 26 Jan 2011
APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection
Biopharmaceuticals Licensing Oncology

HSMN NewsFeed - 18 Jan 2011
Medtronic Revises Design of CoreValve(R) U.S. Pivotal Trial
Devices Interventional Cardiology

HSMN NewsFeed - 18 Jan 2011
JenaValve(TM) reports significant clinical milestone: first-ever successful transcatheter implantation of a 27mm transapical aortic valve prosthesis
Devices Interventional Cardiology

HSMN NewsFeed - 11 Jan 2011
St. Francis Hospital to be Part of Major Nationwide Study Using a Catheter-Based Aortic Valve Replacement
Devices Interventional Cardiology

HSMN NewsFeed - 7 Jan 2011
CardiAQ Valve Technologies (CVT) appoints Rob Michiels as Chief Executive Officer
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 9 Dec 2010
Medtronic CoreValve(R) System Gains CE Mark for New Subclavian Approach to Transcatheter Aortic Valve Implantation
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 17 Nov 2010
ISTA Pharmaceuticals Granted Three-Year Market Exclusivity for BROMDAY
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 2 Nov 2010
JenaValve Technology Initiates Multicenter CE-Mark Study for Its Transapical TAVI System
Devices Cardiology

HSMN NewsFeed - 29 Oct 2010
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 15 Oct 2010
Medtronic Clinical Trial Receives FDA Approval to Evaluate New CoreValve(R) System for Aortic Valve Implantation
Devices Interventional Cardiology FDA

HSMN NewsFeed - 7 Sep 2010
Medtronic Gains CE Mark for Enhanced CoreValve(R) Delivery Catheter System with AccuTrak Stability Layer
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 12 Aug 2010
U.S. District Court Rules Against Lilly Regarding Strattera Patent
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 4 Aug 2010
Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jun 2010
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 11 Jun 2010
APP Pharmaceuticals to Market Oxaliplatin Injection (Liquid) in the U.S.
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jun 2010
Ardian(R) Receives 2010 EuroPCR Innovation Award and Demonstrates Further Durability of Renal Denervation Treatment for Hypertension
Devices Interventional Cardiology

HSMN NewsFeed - 25 May 2010
Multiple European Clinical Registries Show Important Benefits of Medtronic CoreValve(R) Transcatheter Aortic Valve System
Devices Interventional Cardiology

HSMN NewsFeed - 19 May 2010
Embrella Cardiovascular, Inc. Receives European CE Mark Approval for the Embrella Embolic Deflector Device
Devices Interventional Regulatory

HSMN NewsFeed - 22 Apr 2010
Actelion Pharmaceuticals Announces Commercial Availability of Epoprostenol for Injection for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals

HSMN NewsFeed - 18 Mar 2010
Dr. Thomas Hofstaetter Named President and CEO of VaxInnate; Dr. Alan Shaw Assumes New Role as Chief Scientific Officer and Chairman of the Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Feb 2010
Barry Buckland Joins Ancora Pharmaceuticals Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jan 2010
Inovio Appoints Dr. Mark Bagarazzi as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jan 2010
Embrella Cardiovascular, Inc. Completes Successful First Clinical Experience
Devices Interventional

HSMN NewsFeed - 26 Oct 2009
FDA Determines VYVANSE(R) was Properly Granted Five-Year Market Exclusivity
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Oct 2009
Amarin Announces Changes to Its Board and Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Oct 2009
Direct Flow Medical Presents Twelve Month Clinical Results with Their Percutaneous Aortic Valve System at TCT
Devices Interventional Cardiology

HSMN NewsFeed - 14 Aug 2009
Embrella Cardiovascular, Inc. Announces Final Closing of Series B Round
Devices Interventional Venture Capital

HSMN NewsFeed - 26 Jun 2009
Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 29 Apr 2009
Imaging Diagnostic Systems Appoints New Distributor for Italy
Devices Distribution

HSMN NewsFeed - 30 Jan 2009
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
Biopharmaceuticals Litigation

HSMN NewsFeed - 21 Jan 2009
Actavis Receives Approval of Levetiracetam Oral Solution in the U.S.
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 15 Jan 2009
ISTA Pharmaceuticals' New Drug Application for Bepreve(TM) Accepted for Review by U.S. Food and Drug Administration
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 26 Sep 2008
ISTA Pharmaceuticals Receives $65 Million Funding Commitment
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 30 Aug 2008
Monoclonal Antibody Sales to Almost Double in Coming Years
Biopharmaceuticals

HSMN NewsFeed - 21 May 2008
AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer
Biopharmaceuticals Licensing

HSMN NewsFeed - 3 Apr 2008
FDA Approves Rotarix(R) [Rotavirus Vaccine, Live, Oral], the First Vaccine Licensed to Complete the Rotavirus Immunization Series by Four Months of Age
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Mar 2008
Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 14 Mar 2008
FDA Gives Go Ahead for Actavis' Irinotecan Hydrochloride Injection
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 20 Feb 2008
GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral)
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Feb 2008
MedImmune Submits Biologics License Application to FDA for Motavizumab
Biopharmaceuticals

HSMN NewsFeed - 18 Dec 2007
Pfizer to Acquire CovX to Extend Biotherapeutics Investment
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Nov 2007
Bio-advancements Expected to Drive Burn Care Market Growth Up $700 Million
Devices Wound Care

HSMN NewsFeed - 26 Nov 2007
Carbylan Announces $20 Million Series B Financing
Devices Venture Capital

HSMN NewsFeed - 23 Nov 2007
New Data Published in The Lancet Show GSK's ROTARIX(R) Offers Protection Against the Most Common Circulating Rotavirus Types
Biopharmaceuticals

HSMN NewsFeed - 15 Nov 2007
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
Biopharmaceuticals

HSMN NewsFeed - 12 Nov 2007
ISTA Pharmaceuticals Presents Results from Two Phase III Clinical Trials of Xibrom(TM) QD (Once-daily) Formulation at the American Academy of Ophthalmology Annual Meeting
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 23 Oct 2007
Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension
Biopharmaceuticals

HSMN NewsFeed - 22 Oct 2007
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 17 Oct 2007
TomoTherapy Incorporated Announces Strategic Alliance with PTW
Devices Oncology

HSMN NewsFeed - 4 Oct 2007
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Sep 2007
ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
Biopharmaceuticals Licensing

HSMN NewsFeed - 26 Sep 2007
Merck to Donate Three Million Doses of Gardasil(R), its Cervical Cancer Vaccine, to Support Vaccination Programs in Lowest Income Nations
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Sep 2007
New Data Show That GlaxoSmithKline's Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
Biopharmaceuticals

HSMN NewsFeed - 17 Sep 2007
Actavis Confirms its Patent Challenge of King's Avinza(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 7 Sep 2007
Actavis Launches Amlodipine Tablets in the U.S.
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Aug 2007
Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
Biopharmaceuticals Generics FDA Drug Delivery

HSMN NewsFeed - 14 Aug 2007
GlaxoSmithKline's Application for Rotarix(R) is Accepted for Review by the FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Aug 2007
Actavis Receives Approval for Generic Inderal LA Capsules in the U.S.
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 26 Jun 2007
Actavis Launches Generic Adalat(R) CC Tablets in the U.S.
Biopharmaceuticals Generics

HSMN NewsFeed - 29 May 2007
Peplin Appoints Chief Commercial Officer
Biopharmaceuticals Dermatology Oncology Personnel

HSMN NewsFeed - 21 May 2007
Actavis Launches Finasteride 5 mg Tablets in the U.S.
Biopharmaceuticals Generics Urology FDA

HSMN NewsFeed - 15 May 2007
ESTECH COBRA(R) Devices and Patented ''Box Lesion'' Acknowledged as Key Elements in Successful Cardiac Ablation at Recent American Association for Thoracic Surgery 87th Annual Meeting
Devices Cardiology

HSMN NewsFeed - 8 May 2007
MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
Biopharmaceuticals

HSMN NewsFeed - 8 May 2007
ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 23 Apr 2007
Actavis Completes Acquisition of Abrika Pharmaceuticals in the US
Biopharmaceuticals Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 9 Apr 2007
Innovative Pulmonary and PEGylation-Based Therapeutic Product Development Drives Business Strategy of Nektar Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Mar 2007
ADDERALL XR(R) - Shire Files Suit Against Colony Pharmaceuticals, Inc., Actavis, Inc. and Actavis Group hf
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 2 Mar 2007
Actavis Launches Hydrochlorothiazide 12.5 mg Tablets in the U.S.
Biopharmaceuticals Generics

HSMN NewsFeed - 1 Mar 2007
Actavis Receives Approval for Ranitidine Syrup in the U.S.
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 14 Feb 2007
Actavis Launches Alprazolam ER Tablets in the U.S.
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 13 Feb 2007
Merck Updates Prescribing Information for ROTATEQ(R), the Company's Vaccine to Help Prevent Rotavirus Gastroenteritis in Infants and Children
Biopharmaceuticals

HSMN NewsFeed - 8 Feb 2007
ISTA Pharmaceuticals Announces Positive Preliminary Xibrom(TM) Once-daily Formulation Clinical Results From U.S. Phase III Trials
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 18 Jan 2007
GlaxoSmithKline Initiates Head-to-Head Study of Cervical Cancer Vaccines
Biopharmaceuticals

HSMN NewsFeed - 10 Jan 2007
Endovasc Strengthens Management Team by Appointing Chief Financial and Chief Compliance Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Dec 2006
ISTA Pharmaceuticals Submits Investigational New Drug Application for Eye Drop Formulation of Bepotastine for the Treatment of Allergic Conjunctivitis
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 13 Dec 2006
Exercise and Physical Rehabilitation Specialist Joins Endovasc's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Dec 2006
Actelion Ltd. Announces Commencement of Cash Tender Offer for CoTherix, Inc. and HSR Clearance to Acquire CoTherix, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Nov 2006
Concert Pharmaceuticals Raises $48.5 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Nov 2006
Kalypsys Raises $100 Million in a Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Nov 2006
Actelion Announces Definitive Agreement to Acquire U.S.-Based CoTherix, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 6 Nov 2006
Actavis Launches Glipizide ER Tablets in the U.S.
Biopharmaceuticals Generics Endocrinology

HSMN NewsFeed - 27 Oct 2006
Results of PEG-INTRON(R) and REBETOL(R) Study in Retreating Hepatitis C Patients Who Failed Previous Combination Therapy Presented at AASLD
Biopharmaceuticals

HSMN NewsFeed - 2 Oct 2006
Novavax Names Dr. Penny Heaton Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Sep 2006
Mathematical Model Predicts That CERVARIX May Prevent Nearly 80 Percent of Cervical Cancers
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Sep 2006
Endius Launches NorthStar(TM) Cannulated Screw Delivery System
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 27 Sep 2006
Endius Introduces NexPosure(TM)-- A Revolutionary New Product That Provides Surgeons With Posterior MIS Cervical Access
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 22 Sep 2006
Merck and Nicaragua Unveil New Rotavirus Vaccine Demonstration Project at Clinton Global Initiative
Biopharmaceuticals

HSMN NewsFeed - 6 Sep 2006
Actavis Launches Pilocarpine Tablets 7.5mg in the U.S.
Biopharmaceuticals Generics

HSMN NewsFeed - 17 Jul 2006
Endovasc Cites Favorable Market Conditions for its Liprostin Drug
Biopharmaceuticals

HSMN NewsFeed - 12 Jul 2006
Latest Data Confirm GlaxoSmithKline's Proprietary Adjuvant System For Cervarix(TM) Induces a Stronger and More Sustained Immune Response Than a Conventional Adjuvant Formulation
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Jul 2006
ISTA Pharmaceuticals Files New Drug Application with U.S. Food and Drug Administration for T-Pred(TM), a Tobramycin and Prednisolone Acetate Combination Product
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 29 Jun 2006
GlaxoSmithKline Applauds ACIP for New Guidance on Use of HPV Vaccine to Protect Girls and Women Against Cervical Cancer
Biopharmaceuticals

HSMN NewsFeed - 28 Jun 2006
CoTherix Licenses Exclusive Rights to Develop and Commercialize Oral and Inhaled Formulations of Fasudil for the Treatment of PAH and Stable Angina in North America and Europe From Asahi Kasei Pharma
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Jun 2006
FDA Approves Merck's GARDASIL(R), the World's First and Only Cervical Cancer Vaccine
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 5 Jun 2006
New Data Show Cervarix(TM), GSK's HPV 16/18 Cervical Cancer Candidate Vaccine, Is Highly Immunogenic and Well-Tolerated In Women Over 25 Years of Age
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 May 2006
ISTA Pharmaceuticals Is Initiating Phase III Clinical Trials of a New Once-Daily Formulation of Xibrom(TM) for the Treatment of Ocular Pain and Inflammation Following Cataract Surgery
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 26 May 2006
Merck to Create New Patient Assistance Program for Vaccines
Biopharmaceuticals

HSMN NewsFeed - 26 May 2006
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 8 May 2006
Endovasc Announces Agreement with PYRAMID Labs to Manufacture Liprostin for Phase IIIa Trial
Biopharmaceuticals

HSMN NewsFeed - 4 May 2006
ISTA Pharmaceuticals(R) Announces Study Indicating Twice-Daily Dosing of Xibrom(TM) as Equivalent to Four Times a Day of Other Treatments
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 1 May 2006
ISTA Pharmaceuticals Reports Simple Model Predicts Treatment Success With Vitrase(R) in Vitreous Hemorrhage Associated With Diabetes
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 11 Apr 2006
CoTherix Appoints Abhay Joshi as EVP and Chief Technical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Apr 2006
Cervarix(TM), GSK's Candidate Vaccine for Cervical Cancer, Demonstrated Sustained Efficacy for up to 4.5 Years and Broader Protection Against Cancer- Causing HPV Types
Biopharmaceuticals

HSMN NewsFeed - 6 Mar 2006
Endovasc Submits Protocol for Phase III Clinical Trial of Liprostin
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Feb 2006
AVANT Announces that the European Regulatory Authorities Have Approved Rotarix(R) Rotavirus Vaccine
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Feb 2006
GARDASIL(R), Merck's Investigational Cervical Cancer Vaccine, to Receive Priority Review from the U.S. Food and Drug Administration
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Feb 2006
FDA Approves Merck's ROTATEQ(R), The Only Vaccine in the U.S. to Prevent Rotavirus Gastroenteritis, a Leading Cause of Severe Infant Diarrhea
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Feb 2006
ISTA Pharmaceuticals Announces Positive Phase III Results for Tobramycin and Prednisolone Acetate Combination Product
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 30 Jan 2006
ISTA Pharmaceuticals Receives FDA Approval for Expanded Indication of Xibrom(TM) to Treat Pain Following Cataract Surgery
Biopharmaceuticals Ophthalmology Surgery FDA

HSMN NewsFeed - 23 Jan 2006
AVANT Expands Senior Management Team with Appointment of Ronald W. Ellis, Ph.D., Senior Vice President, Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jan 2006
ISTA Pharmaceuticals Announces Acceptance of ISTA's European Marketing Application for Ovine Hyaluronidase for the Treatment of Vitreous Hemorrhage
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 5 Jan 2006
AVANT Immunotherapeutics Says Promise of Rotarix(R) Rotavirus Vaccine for Reducing Deaths, Hospitalizations Due to Rotavirus Disease Highlighted in New England Journal of Medicine
Biopharmaceuticals

HSMN NewsFeed - 4 Jan 2006
In a New Study Published in New England Journal of Medicine, ROTATEQ(R), Merck's Investigational Rotavirus Vaccine, Prevented 98 Percent of Severe Rotavirus Gastroenteritis
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 4 Jan 2006
GlaxoSmithKline's Rotavirus Vaccine Candidate Shown Effective Against Rotavirus Disease
Biopharmaceuticals Gastroenterology

Return to NewsFeed

Additional items found! 108

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 108 additional stories matching:
TAVI
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.